Is Acute myelogenous leukemia (AML) contagious?

Acute myelogenous leukemia (AML) is not contagious and cannot be spread to others through touch, blood, saliva, or any form of social contact. It is a cancer of the blood and bone marrow, meaning it is a non-communicable disease caused by internal genetic mutations rather than an infectious pathogen like a virus or bacteria.

What causes Acute myelogenous leukemia (AML)?

Acute myelogenous leukemia (AML) occurs when the bone marrow begins to produce abnormal, immature blood cells that do not function correctly. These cells crowd out healthy white blood cells, red blood cells, and platelets. The underlying cause is acquired genetic mutations in the DNA of developing blood cells. These mutations are typically somatic, meaning they occur during an individual's lifetime and are not inherited from parents or passed on to children.

Why is there confusion regarding the contagiousness of Acute myelogenous leukemia (AML)?

Because Acute myelogenous leukemia (AML) involves the immune system and requires treatments like chemotherapy that may make patients appear vulnerable or "sick," observers sometimes mistakenly associate the condition with infectious illnesses. There is no biological mechanism for Acute myelogenous leukemia (AML) to spread between people, and living with, hugging, or caring for a patient poses zero risk of transmission to family members or caregivers.

Are there environmental triggers for Acute myelogenous leukemia (AML)?

While the exact cause for most cases remains unknown, certain environmental and clinical factors are recognized as potential contributors to the development of Acute myelogenous leukemia (AML):

• Previous exposure to high-dose radiation.


• Prior treatment with certain chemotherapy drugs (therapy-related AML).


• Long-term exposure to high levels of benzene, a chemical found in cigarette smoke and certain industrial settings.


• Certain underlying blood disorders, such as myelodysplastic syndromes.

Next steps

• Consult an oncologist or hematologist to understand the specific genetic profile of your Acute myelogenous leukemia (AML).


• Connect with the 62 members of the DiseaseMaps community who are navigating Acute myelogenous leukemia (AML) to share experiences and reduce isolation.


• Visit the Leukemia & Lymphoma Society (LLS) for evidence-based emotional and financial support resources.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• National Cancer Institute (NCI): Acute Myeloid Leukemia Treatment (PDQ®)


• NIH Genetic and Rare Diseases Information Center (GARD): Acute Myeloid Leukemia


• The Leukemia & Lymphoma Society (LLS): Understanding AML


• Orphanet: Acute Myeloid Leukemia